DogecoinVM Makes DOGE Transactions 300x Faster 
China Shuts 670 Banks as Bitcoin Eyes Financial Risks 
Yes, government influences wages – but not just in the way you might think 
Why have so few atrocities ever been recognised as genocide? 
AI is driving down the price of knowledge – universities have to rethink what they offer 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Nasdaq Hits Record High as Tech Stocks Lift Wall Street 
Asian Currencies Steady as Dollar Holds Near 18-Month High 
Gold Prices Slip as Strong Dollar and High Treasury Yields Weigh 
The pandemic is still disrupting young people’s careers 
Asian Currencies Mixed as Yen Weakens, Dollar Holds Firm 
Circle Stock Falls 4% as Crypto Selloff Overshadows SAP Pay Expansion 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Kalshi Withdraws PEPE Perpetual Futures Filing 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
Add as a preferred source on Google
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
